NFKB1 and malignant colon neoplasm: NF-κB signaling was robustly activated in the epithelial MC-38 colon cancer cells used in this study in response to treatment with LPS, making them a suitable model to study the cross-talk between the hypoxic and the inflammatory pathways in colon cancer.